Diabetic ketoacidosis induced by aripiprazole in a 12-year-old boy

Diabetes Care

Volumn 31, Issue 6, 2008, Pages

  Dhamija, Radhika ^a,b   Verma, Rajanshu ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; INFUSION FLUID; INSULIN; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ACADEMIC ACHIEVEMENT; ANAMNESIS; BLOOD EXAMINATION; CASE REPORT; CHILD; DIABETIC KETOACIDOSIS; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MOOD DISORDER; POLYDIPSIA; POLYURIA; SCHOOL CHILD; CHEMICALLY INDUCED DISORDER; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CHILD; DIABETIC KETOACIDOSIS; HUMANS; MALE; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA;

EID: 48649104091     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0441     Document Type: Letter

References (6)

1. Davies MA, Sheffler DJ, Roth BL: Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology. CNS Drug Reviews 10:317-336, 2004
2. Vincent W, Harris SB, Houlden RL: Canadian Diabetes Association position paper: Antipsychotic medications and associated risks of weight gain and diabetes. Canadian Journal of Diabetes 29:111-112, 2005
3. Jones JE, Austin JK, Caplan R, Dunn D, Plioplys S, Salpekar JA: Psychiatric disorders in children and adolescents who have epilepsy. PediatRev 29:e9-e14, 2008
4. Boehm G, RacoosinJA, Laughren TP, Katz R: Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: response to consensus statement (Letter). Diabetes Care 27:20882089, 2004
5. Reddymasu S, Bahta E, Levine S, Manas K, Slay LE: Elevated lipase and diabetic ke- toacidosis associated with Aripiprazole. J Pancreas (Online) 7:303-305, 2006
6. Church CO, Stevens DL, Fugate SE: Diabetic ketoacidosis associated with Aripi- prazole. Diabet Med 22:1440-1443, 2005